Brief: Daré Bioscience Reports 2022 Loss Per Share Of $0.37

Dare Bioscience

30/03/2023 13:58

March 30 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE REPORTS FULL YEAR 2022 FINANCIAL RESULTS
AND
PROVIDES A COMPANY UPDATE
    * DARE BIOSCIENCE INC - SEES 2023 SILDENAFIL CREAM, 3.6% FOR
FEMALE SEXUAL AROUSAL DISORDER PHASE 2B TOPLINE DATA
    * DARE BIOSCIENCE INC - SEES 2023 DARE-PDM1 PHASE 1 STUDY
TOPLINE
DATA
    * DARE BIOSCIENCE INC - FY LOSS PER SHARE $0.37
    * DARE BIOSCIENCE INC - SEES  2023 IND AND CLINICAL STUDY
INITIATION ACTIVITIES FOR DARE-VVA1 AND DARE-HRT1
    * DARE BIOSCIENCE INC - SEES 2023  XACIATO™ FIRST COMMERCIAL
SALE

Source text for Eikon:  ID:nGNX3v7NM0 
Further company coverage:  DARE.O 

 ((Reuters.Briefs@thomsonreuters.com;))